BUPROPION HYDROCHLORIDE
- Product NDC
- 50090-6353
- 11-digit product format
- 500906353
- Labeler code
- 50090
- Product ID
- 50090-6353_56dd9f39-2249-497c-a9e7-dc51cb479929
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- BUPROPION HYDROCHLORIDE
- Dosage form
- TABLET, EXTENDED RELEASE
- Route
- ORAL
- Labeler
- A-S Medication Solutions
- Application
- ANDA075932
- Marketing category
- ANDA
- Marketing start
- 2021-12-15
- Substance
- BUPROPION HYDROCHLORIDE
- Active strength
- 150 mg/1
- Pharmacologic classes
- Aminoketone [EPC], Dopamine Uptake Inhibitors [MoA], Increased Dopamine Activity [PE], Increased Norepinephrine Activity [PE], Norepinephrine Uptake Inhibitors [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Related UNII Ingredients
| UNII | Preferred term | Registry number | Matched term |
|---|
| ZG7E5POY8O | BUPROPION HYDROCHLORIDE | 31677-93-7 | BUPROPION HYDROCHLORIDE |
Packages
| Package NDC | 11-digit format | Description | Marketing start | Sample | Exclude flag | Status |
|---|
| 50090-6353-0 | 50090635300 | 60 TABLET, EXTENDED RELEASE in 1 BOTTLE (50090-6353-0) | 2023-02-01 | No | No | Historical |
| 50090-6353-1 | 50090635301 | 30 TABLET, EXTENDED RELEASE in 1 BOTTLE (50090-6353-1) | 2023-02-01 | No | No | Historical |
| 50090-6353-2 | 50090635302 | 180 TABLET, EXTENDED RELEASE in 1 BOTTLE (50090-6353-2) | 2023-02-01 | No | No | Historical |
| 50090-6353-3 | 50090635303 | 90 TABLET, EXTENDED RELEASE in 1 BOTTLE (50090-6353-3) | 2023-02-01 | No | No | Historical |
Related DailyMed Labels
| Title | Manufacturer | Effective date | Type | Version |
|---|
| BUPROPION HYDROCHLORIDE | A-S Medication Solutions | 2024-05-31 | HUMAN PRESCRIPTION DRUG LABEL | 3 |